Breaking Down Kingfa Sci. & Tech. Co., Ltd. Financial Health: Key Insights for Investors

Breaking Down Kingfa Sci. & Tech. Co., Ltd. Financial Health: Key Insights for Investors

CN | Basic Materials | Chemicals - Specialty | SHH

Kingfa Sci. & Tech. Co., Ltd. (600143.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Curious whether Kingfa Sci. & Tech. Co., Ltd. is a growth story or a leveraged risk? In 2024 the company posted revenue of 60.51 billion CNY (up 26.23% from 47.94 billion CNY) and its TTM revenue as of Sept 30, 2025 reached 69.67 billion CNY (a 28.74% y/y gain), while net income surged to 824.62 million CNY in 2024 (a 160.36% jump) and TTM net income hit 1.21 billion CNY with diluted EPS of 0.47 CNY; beneath that top-line momentum sit mixed signals - a debt-to-equity of 131.78%, total debt of 28.31 billion CNY, a current ratio of 1.28 and cash of 5.533 billion CNY, plus operating cash flow of 3.7 billion CNY but negative free cash flow - and valuation metrics that paint another layer of the picture: market cap 27.10 billion CNY, TTM P/E 27.78 (forward P/E 19.04), P/S 0.66 and EV/EBITDA 17.37; dive into the full analysis to unpack how margins (gross 10.92%, operating 5.02%, net 1.73%), profitability ratios (ROE 2.66%, ROA 1.92%), liquidity indicators (quick ratio 0.78), and strategic levers like international sales of 8.79 billion CNY, revenue per employee ~5.32 million CNY, share buybacks of 61.98 million shares and potential bond issuance could influence investor decisions

Kingfa Sci. & Tech. Co., Ltd. (600143.SS) - Revenue Analysis

Kingfa Sci. & Tech. reported robust top-line expansion across 2024-2025, driven by both domestic demand and growing international sales. Revenue climbed from 47.94 billion CNY in 2023 to 60.51 billion CNY in 2024, a 26.23% increase. The momentum continued into 2025 with a TTM revenue of 69.67 billion CNY as of September 30, 2025, up 28.74% year-over-year. Q3 2025 quarterly revenue reached 17.98 billion CNY, a 5.04% increase versus Q3 2024.
  • 2024 total revenue: 60.51 billion CNY (+26.23% vs. 2023)
  • TTM revenue (as of 2025-09-30): 69.67 billion CNY (+28.74% YoY)
  • Q3 2025 revenue: 17.98 billion CNY (+5.04% YoY)
  • Domestic sales (2024): 51.31 billion CNY
  • International sales (2024): 8.79 billion CNY
  • Employees: 13,083; revenue per employee: ~5.32 million CNY
  • Price-to-sales (P/S) ratio: 0.66
Metric Amount (CNY) Growth / Note
Revenue - 2023 47.94 billion Base year
Revenue - 2024 60.51 billion +26.23% YoY
TTM Revenue (as of 2025-09-30) 69.67 billion +28.74% YoY
Q3 2025 Revenue 17.98 billion +5.04% YoY
Domestic Sales (2024) 51.31 billion ~84.8% of total 2024 revenue
International Sales (2024) 8.79 billion ~15.2% of total 2024 revenue
Employees 13,083 -
Revenue per Employee ~5.32 million 2024
Price-to-Sales (P/S) 0.66 Market valuation metric
Revenue mix highlights the company's reliance on the domestic market while maintaining a meaningful international presence. Per-employee productivity (~5.32 million CNY) combined with a P/S of 0.66 suggests revenue scale with an equity valuation that may be attractive relative to peers. Strategic context and corporate priorities are detailed in the company's guiding materials: Mission Statement, Vision, & Core Values (2026) of Kingfa Sci. & Tech. Co., Ltd.

Kingfa Sci. & Tech. Co., Ltd. (600143.SS) Profitability Metrics

Kingfa Sci. & Tech. Co., Ltd. (600143.SS) shows marked improvement in profitability over the past two years, driven by significant net income growth and expanding margins. Key headline figures highlight both recent annual performance and the most-recent trailing twelve months (TTM) results.

  • 2024 net income: 824.62 million CNY (up 160.36% vs. 2023's 316.73 million CNY)
  • TTM net income (as of 2025-09-30): 1.21 billion CNY; diluted EPS: 0.47 CNY
  • Quarterly earnings growth (YoY): 57.99%
Metric Value Notes / Period
Net Income (2024) 824.62 million CNY 2024 annual
Net Income (2023) 316.73 million CNY 2023 annual
TTM Net Income 1.21 billion CNY As of 2025-09-30
Diluted EPS (TTM) 0.47 CNY As of 2025-09-30
Operating Margin 5.02% Latest reported
Net Profit Margin 1.73% Latest reported
Gross Margin 10.92% Latest reported
EBITDA Margin 5.95% Latest reported
Return on Equity (ROE) 2.66% Latest reported
Return on Assets (ROA) 1.92% Latest reported
Quarterly Earnings Growth (YoY) 57.99% Most recent quarter

Investors seeking deeper context on ownership, institutional participation, and investor trends can reference additional profile details here: Exploring Kingfa Sci. & Tech. Co., Ltd. Investor Profile: Who's Buying and Why?

Kingfa Sci. & Tech. Co., Ltd. (600143.SS) - Debt vs. Equity Structure

Key balance-sheet and leverage indicators for Kingfa Sci. & Tech. as of March 31, 2025 reveal a leveraged capital structure with adequate short-term liquidity and measurable capacity to service interest expense.

Metric Value
Total Debt 28.31 billion CNY
Total Liabilities 28.31 billion CNY
Total Equity 21.44 billion CNY
Debt-to-Equity Ratio 131.78%
Current Ratio 1.28
Interest Coverage Ratio 2.06
Debt-to-EBITDA 6.78
2023 Bond Issuance 500 million CNY at 3.5% interest
  • Leverage profile: With total debt exceeding total equity (debt-to-equity 131.78%), Kingfa operates with a meaningful reliance on external financing.
  • Liquidity: A current ratio of 1.28 indicates short-term obligations are covered by current assets, though the margin is not wide.
  • Interest servicing: An interest coverage ratio of 2.06 shows operating income covers interest expense roughly twice over-adequate but sensitive to earnings volatility.
  • Debt intensity vs. earnings: Debt-to-EBITDA of 6.78 points to a moderate-to-high leverage relative to cash operating earnings, implying longer payback under current EBITDA levels.
  • Access to capital markets: The 2023 bond issuance (500 million CNY at 3.5%) demonstrates the company's ability to secure relatively low-cost debt financing.

Investors should consider these metrics alongside operational performance and the company's strategic capital allocation (see Mission Statement, Vision, & Core Values (2026) of Kingfa Sci. & Tech. Co., Ltd.) when assessing risk from financial leverage and refinancing needs.

Kingfa Sci. & Tech. Co., Ltd. (600143.SS) - Liquidity and Solvency

Key balance-sheet and cash-flow metrics through March 31, 2025 highlight a mix of solid operating cash generation and solvency leverage that investors should weigh when assessing short‑term resilience and long‑term financial flexibility.

  • Cash and cash equivalents: 5.533 billion CNY (up 15.17% vs prior period)
  • Quick ratio: 0.78 - below 1.0, implying limited ability to cover current liabilities without converting inventory
  • Operating cash flow (TTM): 3.7 billion CNY - strong cash generation from operations
  • Free cash flow: negative - capital expenditures exceed operating cash flow, placing pressure on liquidity despite strong OCF
  • Total assets: 49.75 billion CNY; total liabilities: 28.31 billion CNY - debt-to-assets ≈ 56.8%
  • Net working capital: positive - current assets exceed current liabilities
Metric Value Comment
Cash & Cash Equivalents (Mar 31, 2025) 5.533 bn CNY 15.17% growth vs prior period
Quick Ratio 0.78 May require inventory liquidation to meet short-term obligations
Operating Cash Flow (TTM) 3.7 bn CNY Indicates strong cash generation from operations
Free Cash Flow Negative CapEx > OCF; consumes cash despite operating strength
Total Assets 49.75 bn CNY Base for asset-backed leverage
Total Liabilities 28.31 bn CNY Resulting debt-to-assets ≈ 56.8%
Net Working Capital Positive Sufficient short-term assets to cover current liabilities

Implications for investors include balancing the comfort of strong operating cash flow and rising cash balances against a quick ratio under 1.0, negative free cash flow, and a leverage profile where liabilities represent a material portion of assets. For further context on shareholder composition and investor interest, see: Exploring Kingfa Sci. & Tech. Co., Ltd. Investor Profile: Who's Buying and Why?

Kingfa Sci. & Tech. Co., Ltd. (600143.SS) - Valuation Analysis

Key market-value and valuation multiples as of July 1, 2025 provide a snapshot of how the market prices Kingfa Sci. & Tech. relative to earnings, book value, revenue and cash generation. The figures below quantify both current market expectations and areas where investors should probe for sustainability or upside.

Metric Value Interpretation
Market Capitalization 27.10 billion CNY Size indicator - mid-cap on Chinese exchanges
TTM P/E 27.78 Moderate premium vs. peers; reflects recent earnings
Forward P/E 19.04 Market expects earnings growth or margin improvement
P/B 1.45 Trading above book - intangible assets/earnings premium
EV/Revenue 0.81 Less than 1× revenue - reasonable top-line valuation
EV/EBITDA 17.37 Relatively elevated - earnings multiple caution
Dividend Yield 0.56% Annualized payout 0.10 CNY per share - modest cash return
EV/FCF 51.37 High multiple vs. free cash flow - potential valuation risk
  • Price-to-earnings context: TTM P/E 27.78 vs. forward P/E 19.04 implies the market discounts near-term earnings weakness or expects material earnings growth going forward.
  • Price-to-book at 1.45 shows investors pay a premium over net asset value, signaling confidence in intangible assets, growth prospects, or higher ROE.
  • EV-based multiples: EV/R 0.81 is relatively conservative, while EV/EBITDA 17.37 and EV/FCF 51.37 indicate the company is valued richly on operating cash and EBITDAR measures.

Investors seeking deeper positioning and shareholder composition details can reference the related investor profile:

Exploring Kingfa Sci. & Tech. Co., Ltd. Investor Profile: Who's Buying and Why?

  • Yield and payout: Dividend yield 0.56% (0.10 CNY/share annualized) is supportive but not a material income proposition; total shareholder return expectations are likely driven by capital appreciation.
  • Valuation risks vs. opportunities: High EV/FCF (51.37) suggests any deterioration in cash generation would pressure valuation; conversely, realization of the forward P/E assumptions would compress multiples and justify current price.

Kingfa Sci. & Tech. Co., Ltd. (600143.SS) - Risk Factors

Key financial and operational risks that investors should weigh when assessing Kingfa Sci. & Tech. Co., Ltd. (600143.SS) are summarized below, with emphasis on leverage, liquidity, cash flow dynamics, and external exposure.

  • High leverage: reported debt-to-equity ratio of 131.78% indicates the company carries debt materially larger than shareholders' equity, raising financial risk and interest-rate sensitivity.
  • Liquidity pressure: a quick ratio of 0.78 suggests current liquid assets may be insufficient to cover short-term liabilities without selling inventory or raising cash.
  • Negative free cash flow: capital expenditures exceed operating cash flow, implying ongoing investments are consuming cash and could constrain liquidity or require external funding.
  • Supply-chain and inflation exposure: reliance on raw materials and global suppliers leaves margins and delivery schedules vulnerable to disruptions and commodity inflation.
  • Macroeconomic sensitivity: observable credit spread widening and correlation with equity market swings indicate the firm's credit and equity prices move with broader economic conditions.
  • Debt-funded growth risks: ongoing reliance on debt financing for expansion and R&D increases refinancing, covenant and solvency risk if not prudently managed.
Metric Reported Value Investor Implication
Debt-to-Equity Ratio 131.78% Elevated leverage; greater interest burden and reduced flexibility in downturns
Quick Ratio 0.78 Potential short-term liquidity gap; reliance on inventory or financing to meet obligations
Free Cash Flow Negative (capex > operating cash flow) Cash burn from investments; may require debt/equity raises or asset sales
Exposure to Supply-Chain & Inflation High (sector-typical) Margins and lead times subject to commodity price swings & logistics disruption
Macroeconomic Sensitivity Elevated (credit spread & equity correlation) Performance may deteriorate in economic downturns or rising rates
Funding Mix Significant reliance on debt Refinancing and covenant risks if market conditions tighten
  • Practical investor considerations:
    • Monitor interest coverage and upcoming maturities to assess refinancing risk.
    • Track operating cash flow vs. capex quarterly to see if negative FCF is temporary (growth capex) or persistent (structural cash shortfall).
    • Watch commodity price trends and supplier concentration metrics that could amplify supply-chain shocks.
    • Compare credit spreads and equity-beta to peers to gauge relative macro sensitivity.

For broader context on shareholder composition and market positioning, see: Exploring Kingfa Sci. & Tech. Co., Ltd. Investor Profile: Who's Buying and Why?

Kingfa Sci. & Tech. Co., Ltd. (600143.SS) - Growth Opportunities

Kingfa Sci. & Tech. is positioned to capitalize on both demand-side and capital-structure catalysts that support continued expansion and shareholder value creation.
  • Revenue momentum: 28.74% year‑over‑year revenue growth, signaling robust end-market demand and capacity to scale sales.
  • Sustainable materials innovation: ongoing R&D and product launches targeting bio-based polymers, high-performance composites and recycled-material solutions.
  • Capital return and balance-sheet optionality: 61.98 million shares repurchased as of April 2025, indicating management confidence in intrinsic value.
  • Planned financing flexibility: potential 2025 bond issuance of CNY 1.0 billion to fund capex, R&D and international expansion.
  • Geographic and end-market diversification: meaningful revenue contributions from both domestic China and international customers across automotive, consumer electronics, packaging and industrial sectors.
  • Productivity and tech push: investments in "new quality productivity" initiatives (automation, digitalization and process R&D) to improve margins and throughput.
Metric Value Context / Implication
YoY Revenue Growth 28.74% Sign of strong demand and pricing/volume expansion
Share Repurchases (to Apr 2025) 61.98 million shares Direct shareholder return; reduces share count and EPS dilution
Potential 2025 Bond CNY 1,000,000,000 Provides low-cost capital for capex, R&D and cross-border M&A
Revenue Mix Domestic + International (diversified) Mitigates regional cyclicality; enables export growth
Strategic Focus Sustainable materials, composites, automation Addresses regulatory and customer shift toward eco‑friendly solutions
  • Near-term growth drivers: ramp of sustainable-material product lines, stronger OEM demand in automotive/electronics, and execution of share repurchase and potential bond proceeds into productive investments.
  • Risks to monitor: implementation risk on international penetration, R&D commercialization timelines, and macro-driven commodity feedstock pressure.
Kingfa Sci. & Tech. Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

DCF model

Kingfa Sci. & Tech. Co., Ltd. (600143.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.